Learning to handle pill side effects: new study for neuroendocrine tumor patients
NCT ID NCT07258810
First seen Dec 16, 2025 · Last updated May 23, 2026 · Updated 20 times
Summary
This study looks at whether a therapeutic education program can help patients with neuroendocrine tumors handle side effects from oral cancer drugs like everolimus and sunitinib. About 100 adults will take part, and researchers will track side effects, hospital visits, and quality of life. The goal is to see if teaching patients to manage their own treatment improves safety and well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE (NE) TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Edouard Herriot University Hospital
Lyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.